nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—CYP2D6—breast cancer	0.202	0.583	CbGaD
Timolol—ABCB1—breast cancer	0.144	0.417	CbGaD
Timolol—ABCB1—Toremifene—breast cancer	0.0452	0.129	CbGbCtD
Timolol—CYP2C19—Lapatinib—breast cancer	0.0409	0.117	CbGbCtD
Timolol—CYP2D6—Idarubicin—breast cancer	0.0353	0.101	CbGbCtD
Timolol—ABCB1—Lapatinib—breast cancer	0.033	0.0943	CbGbCtD
Timolol—CYP2C19—Tamoxifen—breast cancer	0.0205	0.0585	CbGbCtD
Timolol—ABCB1—Vinorelbine—breast cancer	0.0183	0.0523	CbGbCtD
Timolol—CYP2D6—Vinorelbine—breast cancer	0.0172	0.0493	CbGbCtD
Timolol—ABCB1—Tamoxifen—breast cancer	0.0165	0.0472	CbGbCtD
Timolol—ABCB1—Mitoxantrone—breast cancer	0.0161	0.0461	CbGbCtD
Timolol—CYP2D6—Tamoxifen—breast cancer	0.0156	0.0445	CbGbCtD
Timolol—ABCB1—Gemcitabine—breast cancer	0.0142	0.0407	CbGbCtD
Timolol—ABCB1—Paclitaxel—breast cancer	0.0128	0.0368	CbGbCtD
Timolol—ABCB1—Irinotecan—breast cancer	0.0127	0.0363	CbGbCtD
Timolol—ABCB1—Vinblastine—breast cancer	0.0113	0.0322	CbGbCtD
Timolol—CYP2D6—Vinblastine—breast cancer	0.0106	0.0304	CbGbCtD
Timolol—ABCB1—Docetaxel—breast cancer	0.00929	0.0266	CbGbCtD
Timolol—ABCB1—Doxorubicin—breast cancer	0.00692	0.0198	CbGbCtD
Timolol—ABCB1—Methotrexate—breast cancer	0.00671	0.0192	CbGbCtD
Timolol—CYP2D6—Doxorubicin—breast cancer	0.00652	0.0187	CbGbCtD
Timolol—Musculoskeletal discomfort—Docetaxel—breast cancer	4.75e-05	0.000199	CcSEcCtD
Timolol—Headache—Mitoxantrone—breast cancer	4.73e-05	0.000198	CcSEcCtD
Timolol—Headache—Irinotecan—breast cancer	4.73e-05	0.000198	CcSEcCtD
Timolol—Hypotension—Capecitabine—breast cancer	4.72e-05	0.000198	CcSEcCtD
Timolol—Insomnia—Docetaxel—breast cancer	4.72e-05	0.000198	CcSEcCtD
Timolol—Paraesthesia—Docetaxel—breast cancer	4.68e-05	0.000197	CcSEcCtD
Timolol—Alopecia—Methotrexate—breast cancer	4.68e-05	0.000196	CcSEcCtD
Timolol—Vomiting—Gemcitabine—breast cancer	4.67e-05	0.000196	CcSEcCtD
Timolol—Bradycardia—Doxorubicin—breast cancer	4.66e-05	0.000196	CcSEcCtD
Timolol—Dyspnoea—Docetaxel—breast cancer	4.65e-05	0.000195	CcSEcCtD
Timolol—Somnolence—Docetaxel—breast cancer	4.64e-05	0.000195	CcSEcCtD
Timolol—Mental disorder—Methotrexate—breast cancer	4.64e-05	0.000195	CcSEcCtD
Timolol—Rash—Gemcitabine—breast cancer	4.63e-05	0.000194	CcSEcCtD
Timolol—Dermatitis—Gemcitabine—breast cancer	4.63e-05	0.000194	CcSEcCtD
Timolol—Eye disorder—Epirubicin—breast cancer	4.63e-05	0.000194	CcSEcCtD
Timolol—Tinnitus—Epirubicin—breast cancer	4.62e-05	0.000194	CcSEcCtD
Timolol—Malnutrition—Methotrexate—breast cancer	4.61e-05	0.000193	CcSEcCtD
Timolol—Erythema—Methotrexate—breast cancer	4.61e-05	0.000193	CcSEcCtD
Timolol—Headache—Gemcitabine—breast cancer	4.6e-05	0.000193	CcSEcCtD
Timolol—Musculoskeletal discomfort—Capecitabine—breast cancer	4.6e-05	0.000193	CcSEcCtD
Timolol—Cardiac disorder—Epirubicin—breast cancer	4.6e-05	0.000193	CcSEcCtD
Timolol—Vomiting—Fluorouracil—breast cancer	4.59e-05	0.000193	CcSEcCtD
Timolol—Rhinitis—Doxorubicin—breast cancer	4.59e-05	0.000193	CcSEcCtD
Timolol—Dyspepsia—Docetaxel—breast cancer	4.59e-05	0.000193	CcSEcCtD
Timolol—Insomnia—Capecitabine—breast cancer	4.57e-05	0.000192	CcSEcCtD
Timolol—Rash—Fluorouracil—breast cancer	4.56e-05	0.000191	CcSEcCtD
Timolol—Dermatitis—Fluorouracil—breast cancer	4.55e-05	0.000191	CcSEcCtD
Timolol—Paraesthesia—Capecitabine—breast cancer	4.53e-05	0.00019	CcSEcCtD
Timolol—Decreased appetite—Docetaxel—breast cancer	4.53e-05	0.00019	CcSEcCtD
Timolol—Hypersensitivity—Paclitaxel—breast cancer	4.53e-05	0.00019	CcSEcCtD
Timolol—Headache—Fluorouracil—breast cancer	4.53e-05	0.00019	CcSEcCtD
Timolol—Oedema peripheral—Doxorubicin—breast cancer	4.51e-05	0.000189	CcSEcCtD
Timolol—Dysgeusia—Methotrexate—breast cancer	4.51e-05	0.000189	CcSEcCtD
Timolol—Gastrointestinal disorder—Docetaxel—breast cancer	4.5e-05	0.000189	CcSEcCtD
Timolol—Connective tissue disorder—Doxorubicin—breast cancer	4.5e-05	0.000189	CcSEcCtD
Timolol—Dyspnoea—Capecitabine—breast cancer	4.5e-05	0.000189	CcSEcCtD
Timolol—Fatigue—Docetaxel—breast cancer	4.5e-05	0.000189	CcSEcCtD
Timolol—Angiopathy—Epirubicin—breast cancer	4.49e-05	0.000189	CcSEcCtD
Timolol—Nausea—Mitoxantrone—breast cancer	4.48e-05	0.000188	CcSEcCtD
Timolol—Nausea—Irinotecan—breast cancer	4.48e-05	0.000188	CcSEcCtD
Timolol—Immune system disorder—Epirubicin—breast cancer	4.47e-05	0.000188	CcSEcCtD
Timolol—Mediastinal disorder—Epirubicin—breast cancer	4.46e-05	0.000187	CcSEcCtD
Timolol—Pain—Docetaxel—breast cancer	4.46e-05	0.000187	CcSEcCtD
Timolol—Dyspepsia—Capecitabine—breast cancer	4.44e-05	0.000187	CcSEcCtD
Timolol—Arrhythmia—Epirubicin—breast cancer	4.42e-05	0.000186	CcSEcCtD
Timolol—Visual impairment—Doxorubicin—breast cancer	4.41e-05	0.000185	CcSEcCtD
Timolol—Asthenia—Paclitaxel—breast cancer	4.41e-05	0.000185	CcSEcCtD
Timolol—Decreased appetite—Capecitabine—breast cancer	4.39e-05	0.000184	CcSEcCtD
Timolol—Alopecia—Epirubicin—breast cancer	4.38e-05	0.000184	CcSEcCtD
Timolol—Nausea—Gemcitabine—breast cancer	4.37e-05	0.000183	CcSEcCtD
Timolol—Gastrointestinal disorder—Capecitabine—breast cancer	4.36e-05	0.000183	CcSEcCtD
Timolol—Fatigue—Capecitabine—breast cancer	4.35e-05	0.000183	CcSEcCtD
Timolol—Pruritus—Paclitaxel—breast cancer	4.35e-05	0.000183	CcSEcCtD
Timolol—Vision blurred—Methotrexate—breast cancer	4.34e-05	0.000182	CcSEcCtD
Timolol—Mental disorder—Epirubicin—breast cancer	4.34e-05	0.000182	CcSEcCtD
Timolol—Pain—Capecitabine—breast cancer	4.32e-05	0.000181	CcSEcCtD
Timolol—Erythema—Epirubicin—breast cancer	4.31e-05	0.000181	CcSEcCtD
Timolol—Malnutrition—Epirubicin—breast cancer	4.31e-05	0.000181	CcSEcCtD
Timolol—Feeling abnormal—Docetaxel—breast cancer	4.3e-05	0.00018	CcSEcCtD
Timolol—Nausea—Fluorouracil—breast cancer	4.29e-05	0.00018	CcSEcCtD
Timolol—Eye disorder—Doxorubicin—breast cancer	4.28e-05	0.00018	CcSEcCtD
Timolol—Tinnitus—Doxorubicin—breast cancer	4.27e-05	0.000179	CcSEcCtD
Timolol—Gastrointestinal pain—Docetaxel—breast cancer	4.26e-05	0.000179	CcSEcCtD
Timolol—Cardiac disorder—Doxorubicin—breast cancer	4.25e-05	0.000178	CcSEcCtD
Timolol—Tension—Epirubicin—breast cancer	4.23e-05	0.000177	CcSEcCtD
Timolol—Dysgeusia—Epirubicin—breast cancer	4.22e-05	0.000177	CcSEcCtD
Timolol—Diarrhoea—Paclitaxel—breast cancer	4.21e-05	0.000177	CcSEcCtD
Timolol—Nervousness—Epirubicin—breast cancer	4.19e-05	0.000176	CcSEcCtD
Timolol—Feeling abnormal—Capecitabine—breast cancer	4.16e-05	0.000175	CcSEcCtD
Timolol—Angiopathy—Doxorubicin—breast cancer	4.16e-05	0.000174	CcSEcCtD
Timolol—Immune system disorder—Doxorubicin—breast cancer	4.14e-05	0.000174	CcSEcCtD
Timolol—Vertigo—Methotrexate—breast cancer	4.14e-05	0.000174	CcSEcCtD
Timolol—Gastrointestinal pain—Capecitabine—breast cancer	4.13e-05	0.000173	CcSEcCtD
Timolol—Mediastinal disorder—Doxorubicin—breast cancer	4.13e-05	0.000173	CcSEcCtD
Timolol—Body temperature increased—Docetaxel—breast cancer	4.12e-05	0.000173	CcSEcCtD
Timolol—Abdominal pain—Docetaxel—breast cancer	4.12e-05	0.000173	CcSEcCtD
Timolol—Arrhythmia—Doxorubicin—breast cancer	4.09e-05	0.000172	CcSEcCtD
Timolol—Dizziness—Paclitaxel—breast cancer	4.07e-05	0.000171	CcSEcCtD
Timolol—Vision blurred—Epirubicin—breast cancer	4.06e-05	0.00017	CcSEcCtD
Timolol—Alopecia—Doxorubicin—breast cancer	4.05e-05	0.00017	CcSEcCtD
Timolol—Cough—Methotrexate—breast cancer	4.02e-05	0.000169	CcSEcCtD
Timolol—Mental disorder—Doxorubicin—breast cancer	4.01e-05	0.000168	CcSEcCtD
Timolol—Urticaria—Capecitabine—breast cancer	4.01e-05	0.000168	CcSEcCtD
Timolol—Abdominal pain—Capecitabine—breast cancer	3.99e-05	0.000167	CcSEcCtD
Timolol—Body temperature increased—Capecitabine—breast cancer	3.99e-05	0.000167	CcSEcCtD
Timolol—Erythema—Doxorubicin—breast cancer	3.99e-05	0.000167	CcSEcCtD
Timolol—Malnutrition—Doxorubicin—breast cancer	3.99e-05	0.000167	CcSEcCtD
Timolol—Myalgia—Methotrexate—breast cancer	3.92e-05	0.000165	CcSEcCtD
Timolol—Arthralgia—Methotrexate—breast cancer	3.92e-05	0.000165	CcSEcCtD
Timolol—Chest pain—Methotrexate—breast cancer	3.92e-05	0.000165	CcSEcCtD
Timolol—Tension—Doxorubicin—breast cancer	3.91e-05	0.000164	CcSEcCtD
Timolol—Vomiting—Paclitaxel—breast cancer	3.91e-05	0.000164	CcSEcCtD
Timolol—Dysgeusia—Doxorubicin—breast cancer	3.91e-05	0.000164	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.89e-05	0.000163	CcSEcCtD
Timolol—Rash—Paclitaxel—breast cancer	3.88e-05	0.000163	CcSEcCtD
Timolol—Dermatitis—Paclitaxel—breast cancer	3.88e-05	0.000163	CcSEcCtD
Timolol—Discomfort—Methotrexate—breast cancer	3.87e-05	0.000163	CcSEcCtD
Timolol—Nervousness—Doxorubicin—breast cancer	3.87e-05	0.000163	CcSEcCtD
Timolol—Vertigo—Epirubicin—breast cancer	3.87e-05	0.000162	CcSEcCtD
Timolol—Syncope—Epirubicin—breast cancer	3.87e-05	0.000162	CcSEcCtD
Timolol—Headache—Paclitaxel—breast cancer	3.85e-05	0.000162	CcSEcCtD
Timolol—Hypersensitivity—Docetaxel—breast cancer	3.84e-05	0.000161	CcSEcCtD
Timolol—Palpitations—Epirubicin—breast cancer	3.81e-05	0.00016	CcSEcCtD
Timolol—Confusional state—Methotrexate—breast cancer	3.79e-05	0.000159	CcSEcCtD
Timolol—Loss of consciousness—Epirubicin—breast cancer	3.79e-05	0.000159	CcSEcCtD
Timolol—Cough—Epirubicin—breast cancer	3.76e-05	0.000158	CcSEcCtD
Timolol—Anaphylactic shock—Methotrexate—breast cancer	3.76e-05	0.000158	CcSEcCtD
Timolol—Vision blurred—Doxorubicin—breast cancer	3.76e-05	0.000158	CcSEcCtD
Timolol—Asthenia—Docetaxel—breast cancer	3.74e-05	0.000157	CcSEcCtD
Timolol—Infection—Methotrexate—breast cancer	3.73e-05	0.000157	CcSEcCtD
Timolol—Hypertension—Epirubicin—breast cancer	3.72e-05	0.000156	CcSEcCtD
Timolol—Hypersensitivity—Capecitabine—breast cancer	3.72e-05	0.000156	CcSEcCtD
Timolol—Pruritus—Docetaxel—breast cancer	3.69e-05	0.000155	CcSEcCtD
Timolol—Nervous system disorder—Methotrexate—breast cancer	3.69e-05	0.000155	CcSEcCtD
Timolol—Arthralgia—Epirubicin—breast cancer	3.67e-05	0.000154	CcSEcCtD
Timolol—Chest pain—Epirubicin—breast cancer	3.67e-05	0.000154	CcSEcCtD
Timolol—Myalgia—Epirubicin—breast cancer	3.67e-05	0.000154	CcSEcCtD
Timolol—Anxiety—Epirubicin—breast cancer	3.66e-05	0.000153	CcSEcCtD
Timolol—Nausea—Paclitaxel—breast cancer	3.65e-05	0.000153	CcSEcCtD
Timolol—Skin disorder—Methotrexate—breast cancer	3.65e-05	0.000153	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.64e-05	0.000153	CcSEcCtD
Timolol—Hyperhidrosis—Methotrexate—breast cancer	3.63e-05	0.000152	CcSEcCtD
Timolol—Discomfort—Epirubicin—breast cancer	3.63e-05	0.000152	CcSEcCtD
Timolol—Asthenia—Capecitabine—breast cancer	3.62e-05	0.000152	CcSEcCtD
Timolol—Dry mouth—Epirubicin—breast cancer	3.59e-05	0.000151	CcSEcCtD
Timolol—Vertigo—Doxorubicin—breast cancer	3.58e-05	0.00015	CcSEcCtD
Timolol—Anorexia—Methotrexate—breast cancer	3.58e-05	0.00015	CcSEcCtD
Timolol—Syncope—Doxorubicin—breast cancer	3.58e-05	0.00015	CcSEcCtD
Timolol—Pruritus—Capecitabine—breast cancer	3.57e-05	0.00015	CcSEcCtD
Timolol—Diarrhoea—Docetaxel—breast cancer	3.57e-05	0.00015	CcSEcCtD
Timolol—Confusional state—Epirubicin—breast cancer	3.55e-05	0.000149	CcSEcCtD
Timolol—Palpitations—Doxorubicin—breast cancer	3.52e-05	0.000148	CcSEcCtD
Timolol—Anaphylactic shock—Epirubicin—breast cancer	3.52e-05	0.000148	CcSEcCtD
Timolol—Oedema—Epirubicin—breast cancer	3.52e-05	0.000148	CcSEcCtD
Timolol—Hypotension—Methotrexate—breast cancer	3.51e-05	0.000147	CcSEcCtD
Timolol—Loss of consciousness—Doxorubicin—breast cancer	3.51e-05	0.000147	CcSEcCtD
Timolol—Infection—Epirubicin—breast cancer	3.49e-05	0.000147	CcSEcCtD
Timolol—Cough—Doxorubicin—breast cancer	3.48e-05	0.000146	CcSEcCtD
Timolol—Shock—Epirubicin—breast cancer	3.46e-05	0.000145	CcSEcCtD
Timolol—Diarrhoea—Capecitabine—breast cancer	3.45e-05	0.000145	CcSEcCtD
Timolol—Nervous system disorder—Epirubicin—breast cancer	3.45e-05	0.000145	CcSEcCtD
Timolol—Dizziness—Docetaxel—breast cancer	3.45e-05	0.000145	CcSEcCtD
Timolol—Hypertension—Doxorubicin—breast cancer	3.44e-05	0.000144	CcSEcCtD
Timolol—Musculoskeletal discomfort—Methotrexate—breast cancer	3.42e-05	0.000144	CcSEcCtD
Timolol—Skin disorder—Epirubicin—breast cancer	3.42e-05	0.000143	CcSEcCtD
Timolol—Hyperhidrosis—Epirubicin—breast cancer	3.4e-05	0.000143	CcSEcCtD
Timolol—Insomnia—Methotrexate—breast cancer	3.4e-05	0.000143	CcSEcCtD
Timolol—Arthralgia—Doxorubicin—breast cancer	3.4e-05	0.000142	CcSEcCtD
Timolol—Chest pain—Doxorubicin—breast cancer	3.4e-05	0.000142	CcSEcCtD
Timolol—Myalgia—Doxorubicin—breast cancer	3.4e-05	0.000142	CcSEcCtD
Timolol—Anxiety—Doxorubicin—breast cancer	3.38e-05	0.000142	CcSEcCtD
Timolol—Paraesthesia—Methotrexate—breast cancer	3.38e-05	0.000142	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.37e-05	0.000141	CcSEcCtD
Timolol—Discomfort—Doxorubicin—breast cancer	3.35e-05	0.000141	CcSEcCtD
Timolol—Anorexia—Epirubicin—breast cancer	3.35e-05	0.000141	CcSEcCtD
Timolol—Dyspnoea—Methotrexate—breast cancer	3.35e-05	0.000141	CcSEcCtD
Timolol—Somnolence—Methotrexate—breast cancer	3.34e-05	0.00014	CcSEcCtD
Timolol—Dizziness—Capecitabine—breast cancer	3.34e-05	0.00014	CcSEcCtD
Timolol—Dry mouth—Doxorubicin—breast cancer	3.32e-05	0.000139	CcSEcCtD
Timolol—Vomiting—Docetaxel—breast cancer	3.32e-05	0.000139	CcSEcCtD
Timolol—Dyspepsia—Methotrexate—breast cancer	3.31e-05	0.000139	CcSEcCtD
Timolol—Rash—Docetaxel—breast cancer	3.29e-05	0.000138	CcSEcCtD
Timolol—Hypotension—Epirubicin—breast cancer	3.29e-05	0.000138	CcSEcCtD
Timolol—Dermatitis—Docetaxel—breast cancer	3.29e-05	0.000138	CcSEcCtD
Timolol—Confusional state—Doxorubicin—breast cancer	3.28e-05	0.000138	CcSEcCtD
Timolol—Decreased appetite—Methotrexate—breast cancer	3.27e-05	0.000137	CcSEcCtD
Timolol—Headache—Docetaxel—breast cancer	3.27e-05	0.000137	CcSEcCtD
Timolol—Oedema—Doxorubicin—breast cancer	3.25e-05	0.000137	CcSEcCtD
Timolol—Anaphylactic shock—Doxorubicin—breast cancer	3.25e-05	0.000137	CcSEcCtD
Timolol—Gastrointestinal disorder—Methotrexate—breast cancer	3.25e-05	0.000136	CcSEcCtD
Timolol—Fatigue—Methotrexate—breast cancer	3.24e-05	0.000136	CcSEcCtD
Timolol—Infection—Doxorubicin—breast cancer	3.23e-05	0.000136	CcSEcCtD
Timolol—Pain—Methotrexate—breast cancer	3.21e-05	0.000135	CcSEcCtD
Timolol—Vomiting—Capecitabine—breast cancer	3.21e-05	0.000135	CcSEcCtD
Timolol—Musculoskeletal discomfort—Epirubicin—breast cancer	3.2e-05	0.000134	CcSEcCtD
Timolol—Shock—Doxorubicin—breast cancer	3.2e-05	0.000134	CcSEcCtD
Timolol—Nervous system disorder—Doxorubicin—breast cancer	3.19e-05	0.000134	CcSEcCtD
Timolol—Rash—Capecitabine—breast cancer	3.18e-05	0.000134	CcSEcCtD
Timolol—Insomnia—Epirubicin—breast cancer	3.18e-05	0.000134	CcSEcCtD
Timolol—Dermatitis—Capecitabine—breast cancer	3.18e-05	0.000133	CcSEcCtD
Timolol—Headache—Capecitabine—breast cancer	3.16e-05	0.000133	CcSEcCtD
Timolol—Skin disorder—Doxorubicin—breast cancer	3.16e-05	0.000133	CcSEcCtD
Timolol—Paraesthesia—Epirubicin—breast cancer	3.16e-05	0.000133	CcSEcCtD
Timolol—Hyperhidrosis—Doxorubicin—breast cancer	3.15e-05	0.000132	CcSEcCtD
Timolol—Dyspnoea—Epirubicin—breast cancer	3.14e-05	0.000132	CcSEcCtD
Timolol—Somnolence—Epirubicin—breast cancer	3.13e-05	0.000131	CcSEcCtD
Timolol—Anorexia—Doxorubicin—breast cancer	3.1e-05	0.00013	CcSEcCtD
Timolol—Nausea—Docetaxel—breast cancer	3.1e-05	0.00013	CcSEcCtD
Timolol—Feeling abnormal—Methotrexate—breast cancer	3.1e-05	0.00013	CcSEcCtD
Timolol—Dyspepsia—Epirubicin—breast cancer	3.1e-05	0.00013	CcSEcCtD
Timolol—Gastrointestinal pain—Methotrexate—breast cancer	3.07e-05	0.000129	CcSEcCtD
Timolol—Decreased appetite—Epirubicin—breast cancer	3.06e-05	0.000128	CcSEcCtD
Timolol—Hypotension—Doxorubicin—breast cancer	3.04e-05	0.000128	CcSEcCtD
Timolol—Gastrointestinal disorder—Epirubicin—breast cancer	3.04e-05	0.000127	CcSEcCtD
Timolol—Fatigue—Epirubicin—breast cancer	3.03e-05	0.000127	CcSEcCtD
Timolol—Pain—Epirubicin—breast cancer	3.01e-05	0.000126	CcSEcCtD
Timolol—Nausea—Capecitabine—breast cancer	3e-05	0.000126	CcSEcCtD
Timolol—Urticaria—Methotrexate—breast cancer	2.99e-05	0.000125	CcSEcCtD
Timolol—Body temperature increased—Methotrexate—breast cancer	2.97e-05	0.000125	CcSEcCtD
Timolol—Abdominal pain—Methotrexate—breast cancer	2.97e-05	0.000125	CcSEcCtD
Timolol—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.97e-05	0.000124	CcSEcCtD
Timolol—Insomnia—Doxorubicin—breast cancer	2.94e-05	0.000124	CcSEcCtD
Timolol—Paraesthesia—Doxorubicin—breast cancer	2.92e-05	0.000123	CcSEcCtD
Timolol—Dyspnoea—Doxorubicin—breast cancer	2.9e-05	0.000122	CcSEcCtD
Timolol—Feeling abnormal—Epirubicin—breast cancer	2.9e-05	0.000122	CcSEcCtD
Timolol—Somnolence—Doxorubicin—breast cancer	2.89e-05	0.000121	CcSEcCtD
Timolol—Gastrointestinal pain—Epirubicin—breast cancer	2.88e-05	0.000121	CcSEcCtD
Timolol—Dyspepsia—Doxorubicin—breast cancer	2.87e-05	0.00012	CcSEcCtD
Timolol—Decreased appetite—Doxorubicin—breast cancer	2.83e-05	0.000119	CcSEcCtD
Timolol—Gastrointestinal disorder—Doxorubicin—breast cancer	2.81e-05	0.000118	CcSEcCtD
Timolol—Fatigue—Doxorubicin—breast cancer	2.81e-05	0.000118	CcSEcCtD
Timolol—Urticaria—Epirubicin—breast cancer	2.79e-05	0.000117	CcSEcCtD
Timolol—Pain—Doxorubicin—breast cancer	2.78e-05	0.000117	CcSEcCtD
Timolol—Abdominal pain—Epirubicin—breast cancer	2.78e-05	0.000117	CcSEcCtD
Timolol—Body temperature increased—Epirubicin—breast cancer	2.78e-05	0.000117	CcSEcCtD
Timolol—Hypersensitivity—Methotrexate—breast cancer	2.77e-05	0.000116	CcSEcCtD
Timolol—Asthenia—Methotrexate—breast cancer	2.7e-05	0.000113	CcSEcCtD
Timolol—Feeling abnormal—Doxorubicin—breast cancer	2.68e-05	0.000113	CcSEcCtD
Timolol—Gastrointestinal pain—Doxorubicin—breast cancer	2.66e-05	0.000112	CcSEcCtD
Timolol—Pruritus—Methotrexate—breast cancer	2.66e-05	0.000112	CcSEcCtD
Timolol—Hypersensitivity—Epirubicin—breast cancer	2.59e-05	0.000109	CcSEcCtD
Timolol—Urticaria—Doxorubicin—breast cancer	2.59e-05	0.000109	CcSEcCtD
Timolol—Abdominal pain—Doxorubicin—breast cancer	2.57e-05	0.000108	CcSEcCtD
Timolol—Body temperature increased—Doxorubicin—breast cancer	2.57e-05	0.000108	CcSEcCtD
Timolol—Diarrhoea—Methotrexate—breast cancer	2.57e-05	0.000108	CcSEcCtD
Timolol—Asthenia—Epirubicin—breast cancer	2.52e-05	0.000106	CcSEcCtD
Timolol—Pruritus—Epirubicin—breast cancer	2.49e-05	0.000104	CcSEcCtD
Timolol—Dizziness—Methotrexate—breast cancer	2.49e-05	0.000104	CcSEcCtD
Timolol—Diarrhoea—Epirubicin—breast cancer	2.41e-05	0.000101	CcSEcCtD
Timolol—Hypersensitivity—Doxorubicin—breast cancer	2.4e-05	0.000101	CcSEcCtD
Timolol—Vomiting—Methotrexate—breast cancer	2.39e-05	0.0001	CcSEcCtD
Timolol—Rash—Methotrexate—breast cancer	2.37e-05	9.95e-05	CcSEcCtD
Timolol—Dermatitis—Methotrexate—breast cancer	2.37e-05	9.94e-05	CcSEcCtD
Timolol—Headache—Methotrexate—breast cancer	2.35e-05	9.88e-05	CcSEcCtD
Timolol—Asthenia—Doxorubicin—breast cancer	2.34e-05	9.8e-05	CcSEcCtD
Timolol—Dizziness—Epirubicin—breast cancer	2.33e-05	9.76e-05	CcSEcCtD
Timolol—Pruritus—Doxorubicin—breast cancer	2.3e-05	9.66e-05	CcSEcCtD
Timolol—Vomiting—Epirubicin—breast cancer	2.24e-05	9.39e-05	CcSEcCtD
Timolol—Nausea—Methotrexate—breast cancer	2.23e-05	9.37e-05	CcSEcCtD
Timolol—Diarrhoea—Doxorubicin—breast cancer	2.23e-05	9.35e-05	CcSEcCtD
Timolol—Rash—Epirubicin—breast cancer	2.22e-05	9.31e-05	CcSEcCtD
Timolol—Dermatitis—Epirubicin—breast cancer	2.22e-05	9.3e-05	CcSEcCtD
Timolol—Headache—Epirubicin—breast cancer	2.2e-05	9.25e-05	CcSEcCtD
Timolol—Dizziness—Doxorubicin—breast cancer	2.15e-05	9.03e-05	CcSEcCtD
Timolol—Nausea—Epirubicin—breast cancer	2.09e-05	8.77e-05	CcSEcCtD
Timolol—Vomiting—Doxorubicin—breast cancer	2.07e-05	8.68e-05	CcSEcCtD
Timolol—Rash—Doxorubicin—breast cancer	2.05e-05	8.61e-05	CcSEcCtD
Timolol—Dermatitis—Doxorubicin—breast cancer	2.05e-05	8.6e-05	CcSEcCtD
Timolol—Headache—Doxorubicin—breast cancer	2.04e-05	8.56e-05	CcSEcCtD
Timolol—Nausea—Doxorubicin—breast cancer	1.93e-05	8.11e-05	CcSEcCtD
Timolol—CYP2C19—Metabolism—FASN—breast cancer	7.15e-06	0.000108	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—BCHE—breast cancer	7.12e-06	0.000108	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP17A1—breast cancer	7.11e-06	0.000108	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL2—breast cancer	7.07e-06	0.000107	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TERT—breast cancer	7.04e-06	0.000106	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ENO1—breast cancer	7.04e-06	0.000106	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS1—breast cancer	7.04e-06	0.000106	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC5A5—breast cancer	7.03e-06	0.000106	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCND1—breast cancer	7.01e-06	0.000106	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—JUN—breast cancer	7e-06	0.000106	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGFR1—breast cancer	6.99e-06	0.000106	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	6.99e-06	0.000106	CbGpPWpGaD
Timolol—ABCB1—Metabolism—FASN—breast cancer	6.98e-06	0.000105	CbGpPWpGaD
Timolol—ABCB1—Metabolism—BCHE—breast cancer	6.95e-06	0.000105	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CTNNB1—breast cancer	6.94e-06	0.000105	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HIF1A—breast cancer	6.89e-06	0.000104	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC5A5—breast cancer	6.86e-06	0.000104	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGFR1—breast cancer	6.84e-06	0.000103	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MMP9—breast cancer	6.81e-06	0.000103	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NQO1—breast cancer	6.79e-06	0.000103	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC2A1—breast cancer	6.79e-06	0.000103	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1A—breast cancer	6.78e-06	0.000103	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NCOA2—breast cancer	6.78e-06	0.000102	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PTEN—breast cancer	6.77e-06	0.000102	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HIF1A—breast cancer	6.74e-06	0.000102	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—LEP—breast cancer	6.72e-06	0.000102	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CAV1—breast cancer	6.66e-06	0.000101	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.65e-06	0.000101	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC2A1—breast cancer	6.63e-06	0.0001	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NQO1—breast cancer	6.63e-06	0.0001	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP3A4—breast cancer	6.62e-06	0.0001	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MAPK8—breast cancer	6.62e-06	0.0001	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AKT1—breast cancer	6.6e-06	9.98e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.59e-06	9.96e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KDR—breast cancer	6.58e-06	9.96e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—LEP—breast cancer	6.58e-06	9.94e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—FASN—breast cancer	6.57e-06	9.94e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—BCHE—breast cancer	6.55e-06	9.9e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CAV1—breast cancer	6.51e-06	9.85e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1B1—breast cancer	6.51e-06	9.84e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC5A5—breast cancer	6.47e-06	9.78e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP3A4—breast cancer	6.46e-06	9.77e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KDR—breast cancer	6.44e-06	9.74e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ESR1—breast cancer	6.42e-06	9.7e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HSP90AA1—breast cancer	6.38e-06	9.65e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1B1—breast cancer	6.35e-06	9.61e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FN1—breast cancer	6.34e-06	9.58e-05	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	6.32e-06	9.55e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ESR1—breast cancer	6.28e-06	9.49e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SRC—breast cancer	6.28e-06	9.49e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	6.26e-06	9.47e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC2A1—breast cancer	6.24e-06	9.44e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NQO1—breast cancer	6.24e-06	9.44e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HSP90AA1—breast cancer	6.23e-06	9.42e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NCOA1—breast cancer	6.21e-06	9.39e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	6.2e-06	9.38e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FN1—breast cancer	6.2e-06	9.37e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	6.13e-06	9.26e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—STK11—breast cancer	6.12e-06	9.25e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP19A1—breast cancer	6.12e-06	9.25e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—breast cancer	6.11e-06	9.24e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP3A4—breast cancer	6.09e-06	9.21e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	6.07e-06	9.17e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	6.07e-06	9.17e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APC—breast cancer	6.07e-06	9.17e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KIT—breast cancer	6.07e-06	9.17e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NCOA1—breast cancer	6.06e-06	9.16e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—STAT3—breast cancer	6.05e-06	9.15e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGF—breast cancer	6e-06	9.07e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1B1—breast cancer	5.99e-06	9.05e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—STK11—breast cancer	5.97e-06	9.03e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP19A1—breast cancer	5.97e-06	9.03e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APC—breast cancer	5.93e-06	8.97e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	5.93e-06	8.97e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KIT—breast cancer	5.93e-06	8.97e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HSP90AA1—breast cancer	5.87e-06	8.88e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGF—breast cancer	5.87e-06	8.87e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	5.81e-06	8.78e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MAPK3—breast cancer	5.78e-06	8.74e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.74e-06	8.69e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NCOA1—breast cancer	5.71e-06	8.64e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BRAF—breast cancer	5.7e-06	8.62e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—COMT—breast cancer	5.69e-06	8.6e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	5.68e-06	8.59e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTP1—breast cancer	5.66e-06	8.56e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP19A1—breast cancer	5.63e-06	8.51e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—STK11—breast cancer	5.63e-06	8.51e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MYC—breast cancer	5.62e-06	8.5e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TGFB1—breast cancer	5.61e-06	8.48e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HMOX1—breast cancer	5.58e-06	8.44e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BRAF—breast cancer	5.58e-06	8.43e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ITPR1—breast cancer	5.57e-06	8.42e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF1—breast cancer	5.55e-06	8.4e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—COMT—breast cancer	5.55e-06	8.4e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT2—breast cancer	5.55e-06	8.39e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTP1—breast cancer	5.53e-06	8.36e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—breast cancer	5.53e-06	8.36e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—breast cancer	5.5e-06	8.32e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HMOX1—breast cancer	5.45e-06	8.24e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ITPR1—breast cancer	5.44e-06	8.22e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF1—breast cancer	5.43e-06	8.21e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT2—breast cancer	5.43e-06	8.21e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—breast cancer	5.41e-06	8.17e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ABCB1—breast cancer	5.36e-06	8.1e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	5.33e-06	8.06e-05	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	5.28e-06	7.99e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	5.27e-06	7.97e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TYMS—breast cancer	5.26e-06	7.96e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—COMT—breast cancer	5.23e-06	7.91e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—KRAS—breast cancer	5.22e-06	7.89e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	5.22e-06	7.89e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTP1—breast cancer	5.21e-06	7.87e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NCOR1—breast cancer	5.2e-06	7.87e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTM1—breast cancer	5.2e-06	7.87e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PLA2G4A—breast cancer	5.2e-06	7.87e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KRAS—breast cancer	5.2e-06	7.86e-05	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	5.17e-06	7.81e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	5.16e-06	7.8e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TYMS—breast cancer	5.14e-06	7.77e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HMOX1—breast cancer	5.14e-06	7.77e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ITPR1—breast cancer	5.12e-06	7.75e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—KRAS—breast cancer	5.11e-06	7.72e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PLA2G4A—breast cancer	5.08e-06	7.68e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NCOR1—breast cancer	5.08e-06	7.68e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTM1—breast cancer	5.08e-06	7.68e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOS3—breast cancer	5.04e-06	7.61e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GPX1—breast cancer	4.98e-06	7.53e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1A1—breast cancer	4.93e-06	7.46e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ABCB1—breast cancer	4.93e-06	7.45e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOS3—breast cancer	4.93e-06	7.45e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ERCC2—breast cancer	4.89e-06	7.4e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GPX1—breast cancer	4.86e-06	7.35e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TYMS—breast cancer	4.84e-06	7.32e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1A1—breast cancer	4.81e-06	7.28e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	4.8e-06	7.25e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NCOR1—breast cancer	4.79e-06	7.24e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.79e-06	7.24e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTM1—breast cancer	4.79e-06	7.24e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MDM2—breast cancer	4.78e-06	7.22e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ERCC2—breast cancer	4.78e-06	7.22e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CA—breast cancer	4.77e-06	7.22e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RAF1—breast cancer	4.76e-06	7.2e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RELA—breast cancer	4.74e-06	7.17e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ERBB2—breast cancer	4.71e-06	7.12e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	4.69e-06	7.09e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MDM2—breast cancer	4.67e-06	7.07e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RAF1—breast cancer	4.66e-06	7.04e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MTOR—breast cancer	4.65e-06	7.03e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	4.65e-06	7.03e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RELA—breast cancer	4.64e-06	7.01e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—breast cancer	4.62e-06	6.98e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ERBB2—breast cancer	4.61e-06	6.97e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—MTHFR—breast cancer	4.6e-06	6.95e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GPX1—breast cancer	4.58e-06	6.93e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	4.55e-06	6.87e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MTOR—breast cancer	4.55e-06	6.87e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1A1—breast cancer	4.54e-06	6.86e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ERCC2—breast cancer	4.5e-06	6.8e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—MTHFR—breast cancer	4.49e-06	6.79e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL8—breast cancer	4.47e-06	6.75e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—HRAS—breast cancer	4.44e-06	6.71e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HRAS—breast cancer	4.42e-06	6.68e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL8—breast cancer	4.37e-06	6.61e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	4.36e-06	6.6e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—HRAS—breast cancer	4.34e-06	6.56e-05	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	4.31e-06	6.52e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CASP3—breast cancer	4.28e-06	6.46e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL2—breast cancer	4.27e-06	6.45e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	4.27e-06	6.45e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6—breast cancer	4.25e-06	6.42e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CAV1—breast cancer	4.24e-06	6.41e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MTHFR—breast cancer	4.23e-06	6.4e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6—breast cancer	4.23e-06	6.39e-05	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	4.22e-06	6.38e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CASP3—breast cancer	4.18e-06	6.32e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL2—breast cancer	4.18e-06	6.31e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCND1—breast cancer	4.16e-06	6.29e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6—breast cancer	4.15e-06	6.28e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JUN—breast cancer	4.15e-06	6.28e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CAV1—breast cancer	4.14e-06	6.26e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	4.12e-06	6.23e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCND1—breast cancer	4.07e-06	6.15e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JUN—breast cancer	4.06e-06	6.14e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.05e-06	6.13e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP9—breast cancer	4.04e-06	6.11e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	4.03e-06	6.09e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	4.03e-06	6.09e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTEN—breast cancer	4.02e-06	6.07e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP9—breast cancer	3.95e-06	5.98e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	3.94e-06	5.95e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAPK8—breast cancer	3.93e-06	5.94e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTEN—breast cancer	3.93e-06	5.94e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT1—breast cancer	3.92e-06	5.92e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CAV1—breast cancer	3.9e-06	5.9e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT1—breast cancer	3.9e-06	5.9e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CG—breast cancer	3.86e-06	5.84e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAPK8—breast cancer	3.84e-06	5.81e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT1—breast cancer	3.83e-06	5.8e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CG—breast cancer	3.77e-06	5.7e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SRC—breast cancer	3.72e-06	5.63e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SRC—breast cancer	3.64e-06	5.51e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—breast cancer	3.63e-06	5.49e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—STAT3—breast cancer	3.59e-06	5.43e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CG—breast cancer	3.55e-06	5.37e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—breast cancer	3.55e-06	5.37e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—STAT3—breast cancer	3.51e-06	5.31e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAPK3—breast cancer	3.43e-06	5.19e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CD—breast cancer	3.4e-06	5.14e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAPK3—breast cancer	3.36e-06	5.08e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALB—breast cancer	3.35e-06	5.07e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MYC—breast cancer	3.34e-06	5.05e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TGFB1—breast cancer	3.33e-06	5.03e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CD—breast cancer	3.32e-06	5.01e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALB—breast cancer	3.27e-06	4.95e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MYC—breast cancer	3.27e-06	4.94e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—breast cancer	3.26e-06	4.94e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TGFB1—breast cancer	3.26e-06	4.92e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NOS3—breast cancer	3.21e-06	4.85e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—breast cancer	3.19e-06	4.83e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NOS3—breast cancer	3.13e-06	4.73e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CD—breast cancer	3.12e-06	4.72e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KRAS—breast cancer	3.08e-06	4.66e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALB—breast cancer	3.08e-06	4.66e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KRAS—breast cancer	3.02e-06	4.56e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CB—breast cancer	2.96e-06	4.48e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NOS3—breast cancer	2.95e-06	4.46e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS2—breast cancer	2.93e-06	4.44e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CB—breast cancer	2.89e-06	4.37e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS2—breast cancer	2.86e-06	4.33e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	2.83e-06	4.28e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	2.77e-06	4.19e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—breast cancer	2.74e-06	4.14e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CB—breast cancer	2.72e-06	4.12e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS2—breast cancer	2.7e-06	4.08e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—breast cancer	2.68e-06	4.05e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HRAS—breast cancer	2.62e-06	3.96e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HRAS—breast cancer	2.56e-06	3.88e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTEN—breast cancer	2.56e-06	3.87e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6—breast cancer	2.51e-06	3.79e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTEN—breast cancer	2.5e-06	3.78e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6—breast cancer	2.45e-06	3.71e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTEN—breast cancer	2.35e-06	3.56e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT1—breast cancer	2.31e-06	3.5e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT1—breast cancer	2.26e-06	3.42e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CA—breast cancer	1.8e-06	2.73e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CA—breast cancer	1.76e-06	2.66e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CA—breast cancer	1.66e-06	2.51e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKT1—breast cancer	1.47e-06	2.23e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKT1—breast cancer	1.44e-06	2.18e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKT1—breast cancer	1.36e-06	2.05e-05	CbGpPWpGaD
